0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Kits > Glycoprotein E (VZV) > RAS-T132

Human Anti-Varicella Zoster Virus Antibody IgG Titer Serologic Assay Kit (gE)

For research use only.

Order Now

IDComponentsSize
RAS132-C01Pre-coated Glycoprotein E (VZV) Microplate1 plate
RAS132-C02Positive Control100 μL
RAS132-C03Negative Control100 μL
RAS132-C04HRP-Anti-Human IgG50 μL
RAS132-C0510 x Washing Buffer 50 mL
RAS132-C06Dilution Buffer50 mL
RAS132-C07Substrate Solution12 mL
RAS132-C08Stop Solution7 mL
  • Background
    Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Human Anti-Varicella Zoster Virus Antibody IgG Titer Serologic Assay Kit (gE) to detection the IgG(GE) titer level in human serum during the clinical stage of vaccine development.
  • Application

    This kit is developed for titer detection of Anti-Varicella Zoster Virus Antibody IgG (gE) in Human serum.

    It is for research use only.

  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This assay kit employs a standard indirect-ELISA format, providing a rapid detection of Anti-VZV gE antibodies in Human serum by Glycoprotein E (VZV). The Kit consists of Pre-coated Glycoprotein E (VZV) Microplate, an Positive Control, an Negative Control, an HRP-Anti-Human IgG secondary antibody.

    Your experiment will include 4 simple steps:

    a) The samples and Control are diluted by Dilution Buffer.Add your sample to the plate.

    b) Add diluted Secondary antibody HRP-Anti-Human IgG to the plate. The Secondary antibody is diluted by Dilution Buffer.

    c) Wash the plate and add TMB or other colorimetric HRP substrate.

    d) Stop the substrate reaction by add diluted acid. Absorbance (OD) is calculate as the absorbance at 450 nm minus the absorbance at 630 nm to remove background prior to statistical analysis. The OD Value reflects the amount of antibody bound.

Typical Data Please refer to Ds document for the assay protocol.
 Glycoprotein E (VZV) TYPICAL DATA

For determination of antibody titer: the positive sample was diluted with a gradient, and the antibody titer of the sample corresponds to the highest dilution factor that still yields a positive reading.

  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €590.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:1 Details
  • Latest Research Phase:Phase 1 Clinical

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message